During the past decade, West China Second University Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 4 clinical trials were completed, i.e. on average, 9.8% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 4 clinical trials were completed. i.e. 19% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West China Second University Hospital" #1 sponsor was "West China Second University Hospital" with 5 trials, followed by "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 3 trials sponsored, "Peking Union Medical College Hospital" with 3 trials sponsored, "Zai Lab (Shanghai) Co., Ltd." with 3 trials sponsored and "Chengdu University of Traditional Chinese Medicine" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West China Second University Hospital" #1 collaborator was "West China Second University Hospital" with 9 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 3 trials as a collaborator, "Shengjing Hospital" with 3 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 2 trials as a collaborator and "LinkDoc Technology (Beijing) Co. Ltd." with 2 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "West China Second University Hospital" are "Ovarian Cancer" (4 trials), "Fallopian Tube Cancer" (3 trials), "Pelvic Organ Prolapse" (3 trials), "COVID-19" (2 trials) and "Duchenne Muscular Dystrophy" (2 trials). Many other conditions were trialed in "West China Second University Hospital" in a lesser frequency.

Most popular intervention types in "West China Second University Hospital" are "Drug" (26 trials), "Biological" (7 trials), "Procedure" (4 trials), "Other" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Corticosteroids" (2 trials) and "High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule" (2 trials). Other intervention names were less common.

The vast majority of trials in "West China Second University Hospital" are 24 trials for "Female" genders, 14 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are 23 active trials in "West China Second University Hospital". 3 are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in West China Second University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in West China Second University Hospital, 9 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".